US cases nearly doubled in 2021 from 756 to 1,471, says the CDC report. Another reason for concern was the increase of cases that became "resistant to echinocandins" which is the antifungal medicine most recommended for treatment of the infection. Dr Lyman, told CBS News the rise "emphasises the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control"